Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Irina S Bulavina"'
Autor:
Irina V Kolyadina, Irina S Bulavina, Vladislav V Petkau, Natalia V Strakhova, Vera A Gorbunova, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Inna P Gan'shina, Tatiana Iu Semiglazova, Aleksei G Manikhas, Natalia A Raevskaia, Ilia M Itkin, Svetlana V Khokhlova, Dmitrii V Filonenko, Viktor E Gol'dberg, Natalia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Liubov I Vladimirova, Natalia M Tikhanovskaia, Elena V Karabina, Guzel Z Mukhametshina, Alfiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Andrei E Orlov, Iuliia V Kostalanova, Natalia V Levchenko, Mikhail A Osipov, Tatiana V Karandeeva, Irina V Evstigneeva, Igor S Chernov, Dzheims Dzh Kolokolov, Anton Iu Povyshev, Alina S Shatokhina, Elena M Cherniakova, Oksana N Shkodenko, Evgeniia S Kuz'mina
Publikováno v:
Современная онкология, Vol 21, Iss 2, Pp 17-24 (2019)
Aim. Eribulin is an active cytostatic, associated with a wide range of mechanisms of antitumor effects, but eribulin efficiency and safety in patients with breast cancer (BC), associated with cerebral metastases are still poorly understood. Materials
Externí odkaz:
https://doaj.org/article/5f21fe71ca7c49f6a857b2579dfadccd
Autor:
Dina D. Sakaeva, Irina S. Bulavina
Publikováno v:
Современная онкология, Vol 23, Iss 4, Pp 685-694 (2021)
The data of recent years indicate the steady increase in the frequency of incidence of brain metastases in many localizations of malignant tumors. Non-small cell lung cancer (NSCLC) is the most common cause, that can affect the central nervous system
Autor:
Mikhail A Osipov, Iuliia V Kostalanova, Elena Karabina, Vera A Gorbunova, Dmitrii M Ponomarenko, Evgeniia S Kuz'mina, Al'fiia I Khasanova, Elena M Cherniakova, Natalia V Strakhova, Tat'iana V Karandeeva, Natal'ia V Levchenko, Inna P. Ganshina, Guzel' Z Mukhametshina, S V Khokhlova, Mikhail V Shaidorov, Tat'iana Iu Semiglazova, Irina S Bulavina, Liubov' I Vladimirova, Elena V. Artamonova, Dzheims Dzh Kolokolov, Il'ia M Itkin, Alina S Shatokhina, Aleksei G Manikhas, Larisa Bolotina, Natal'ia A Raevskaia, Igor' S Chernov, Oksana N Shkodenko, Dmitrii V Filonenko, N. O. Popova, V E Goldberg, Natal'ia M Tikhanovskaia, Irina V. Kolyadina, Sufiia Z Safina, Andrei E Orlov, Liudmila V Manziuk, Valentina E Shikina, Liudmila G. Zhukova, Irina V. Evstigneeva, Anton Iu Povyshev, Elena I. Kovalenko, Vladislav V Petkau
Publikováno v:
Современная онкология, Vol 21, Iss 2, Pp 17-24 (2019)
Aim. Eribulin is an active cytostatic, associated with a wide range of mechanisms of antitumor effects, but eribulin efficiency and safety in patients with breast cancer (BC), associated with cerebral metastases are still poorly understood. Materials